Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 177-183, April 2010

Novel oncolytic viruses: Riding high on the next wave?

Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada

published online 11 March 2010.

Abstract 

The use of viruses as targeted cancer therapy has shown significant promise, and the list of oncolytic viruses continue to grow. The interest in unexplored viruses as oncolytic agents is a natural corollary to the successes and challenges of those already being examined in the clinical setting. Are these ‘new’ viruses any more effective than their predecessors? What are the benefits of refining current clinical candidates compared to searching for new ones? This review briefly describes some of these novel oncolytic viruses. It also examines the issues that arise in comparing them to each other. We believe that the viral mechanism of action is a key factor to success and suggest guidelines by which all oncolytic virus candidates could be evaluated.

Keywords: Tumor, Virus, Oncolytic

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1359-6101(10)00023-7

doi:10.1016/j.cytogfr.2010.02.012

Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 177-183, April 2010